Engineering butyrate-producing Lachnospiraceae to treat metabolic disease

No abstract is available for this paper.

• Publication year

  2025

• Venue

  bioRxiv

• Publication date

  2025-11-09

• Fields of study

  Biology, Medicine, Engineering, Environmental Science

• Identifiers
  DOI 10.1101/2025.11.08.687059PMID 41279522PMCID PMC12637665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut.

  2025cited by this paper
• Repurposing the bacterial surface display technology for drug delivery.

  2025cited by this paper
• Controlled colonization of the human gut with a genetically engineered microbial therapeutic.

  2025cited by this paper
• Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease

  2025cited by this paper
• Designing live bacterial therapeutics for cancer.

  2025cited by this paper
• Metabolic dysfunction–associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations

  2025influential reference
• Synthetically programmed antioxidant delivery by a domesticated skin commensal.

  2025cited by this paper
• Coprococcus protects against high-fat diet-induced nonalcoholic fatty liver disease in mice.

  2024influential reference
• Rapid design of bacteriophage cocktails to suppress the burden and virulence of gut-resident carbapenem-resistant Klebsiella pneumoniae.

  2024cited by this paper
• IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis.

  2024cited by this paper
• A synbiotic of Anaerostipes caccae and lactulose prevents and treats food allergy in mice.

  2024cited by this paper
• An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

  2024cited by this paper
• A randomized, double-blinded, phase 2 trial of EDP1815, an oral immunomodulatory preparation of Prevotella histicola, in adults with mild-to-moderate plaque psoriasis

  2024cited by this paper
• Engineered skin bacteria induce antitumor T cell responses against melanoma

  2023cited by this paper
• A molecular toolkit for heterologous protein secretion across Bacteroides species

  2023cited by this paper
• Synergy and oxygen adaptation for development of next-generation probiotics

  2023cited by this paper
• Genetic Engineering of Resident Bacteria in the Gut Microbiome

  2023cited by this paper
• VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

  2023cited by this paper
• Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut.

  2023cited by this paper
• SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.

  2022cited by this paper
• Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome.

  2022cited by this paper
• Genetically stable CRISPR-based kill switches for engineered microbes

  2022cited by this paper
• SignalP 6.0 predicts all five types of signal peptides using protein language models

  2022influential reference
• clusterProfiler 4.0: A universal enrichment tool for interpreting omics data

  2021cited by this paper
• Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes

  2021cited by this paper
• A Computational Framework for Identifying Promoter Sequences in Nonmodel Organisms Using RNA-seq Data Sets.

  2021cited by this paper
• Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells

  2020cited by this paper
• Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity

  2020cited by this paper
• Functional and Genomic Variation between Human-Derived Isolates of Lachnospiraceae Reveals Inter- and Intra-Species Diversity.

  2020cited by this paper
• Spatially distinct physiology of Bacteroides fragilis within the proximal colon of gnotobiotic mice

  2020cited by this paper
• Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus

  2019cited by this paper
• A Xylose-Inducible Expression System and a CRISPR Interference Plasmid for Targeted Knockdown of Gene Expression in Clostridioides difficile

  2019cited by this paper
• Programmable bacteria induce durable tumor regression and systemic antitumor immunity

  2019cited by this paper
• A Strongly Fluorescing Anaerobic Reporter and Protein-Tagging System for Clostridium Organisms Based on the Fluorescence-Activating and Absorption-Shifting Tag Protein (FAST)

  2019cited by this paper
• Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases

  2019cited by this paper
• Heterologous gene expression in the human gut bacteria Eubacterium rectale and Roseburia inulinivorans by means of conjugative plasmids.

  2019cited by this paper
• B cell superantigens in the human intestinal microbiota

  2019cited by this paper
• A Targetron-Recombinase System for Large-Scale Genome Engineering of Clostridia

  2019cited by this paper
• ShinyGO: a graphical gene-set enrichment tool for animals and plants

  2019cited by this paper
• Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT.

  2018cited by this paper
• Healthy infants harbor intestinal bacteria that protect against food allergy

  2018cited by this paper
• Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice

  2018cited by this paper
• Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model

  2018cited by this paper
• Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria

  2018cited by this paper
• Depletion of microbiome-derived molecules in the host using Clostridium genetics

  2018cited by this paper
• Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism

  2018cited by this paper
• Using CRISPR-Cas9-mediated genome editing to generate C. difficile mutants defective in selenoproteins synthesis

  2017cited by this paper
• Rational Design of Evolutionarily Stable Microbial Kill Switches.

  2017cited by this paper
• DADA2: High resolution sample inference from Illumina amplicon data

  2016cited by this paper
• Interleukin-22 Promotes Intestinal Stem Cell-Mediated Epithelial Regeneration

  2015cited by this paper
• Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells.

  2015cited by this paper
• Discovery of intramolecular trans-sialidases in human gut microbiota suggests novel mechanisms of mucosal adaptation

  2015influential reference
• Programming a Human Commensal Bacterium, Bacteroides thetaiotaomicron, to Sense and Respond to Stimuli in the Murine Gut Microbiota.

  2015cited by this paper
• The MEME Suite

  2015influential reference
• Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

  2014cited by this paper
• Prokka: rapid prokaryotic genome annotation

  2014cited by this paper
• Precision microbiome restoration of bile acid-mediated resistance to Clostridium difficile

  2014cited by this paper
• Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes

  2014cited by this paper
• featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

  2013cited by this paper
• Therapeutic opportunities of the IL-22–IL-22R1 system

  2013cited by this paper
• STAR: ultrafast universal RNA-seq aligner

  2013cited by this paper
• Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

  2013cited by this paper
• Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation

  2013cited by this paper
• Fast gapped-read alignment with Bowtie 2

  2012cited by this paper
• Metagenomic biomarker discovery and explanation

  2011cited by this paper
• Clostridium difficile Has Two Parallel and Essential Sec Secretion Systems*

  2011cited by this paper
• The ClosTron: Mutagenesis in Clostridium refined and streamlined.

  2010cited by this paper
• Enzymatic assembly of DNA molecules up to several hundred kilobases

  2009cited by this paper
• A modular system for Clostridium shuttle plasmids.

  2009cited by this paper
• Targeted gene inactivation in Clostridium phytofermentans shows that cellulose degradation requires the family 9 hydrolase Cphy3367

  2009cited by this paper
• Discovering Sequence Motifs with Arbitrary Insertions and Deletions

  2008influential reference
• Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy

  2007cited by this paper
• The ClosTron: a universal gene knock-out system for the genus Clostridium.

  2007cited by this paper
• Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

  2000cited by this paper
• Molecular Systems Biology Peer Review Process File Generalized Bacterial Genome Editing Using Mobile Group Ii Introns and Cre-lox Transaction Report

  year unknowncited by this paper

• Targeting Lachnospiraceae through Diet: A Functional Food Approach to Combat Food Allergy

  2026cites this paper